Nemaura Medical, Inc.

Nemaura Medical, Inc.

OOTC:NMRD
0.00
USD
0.00
(0.00%)
-0.38EPS
Nov 17Next Earn

Important Dates

Nemaura Medical, Inc.'s next confirmed earnings release is scheduled for November 17, 2026.

Earnings Date11/17/2026

Share Statistics

As of December 31, 2023, Nemaura Medical, Inc. has 28.90M shares outstanding.

Shares Outstanding28.90M

Financial Position

As of December 31, 2023, Nemaura Medical, Inc. maintains a current ratio of 0.19, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -110.19, indicating conservative leverage, while an interest coverage ratio of -1.63 demonstrates limited ability to service its debt obligations.

Current Ratio0.19
Quick Ratio0.02
Debt / Equity-110.19
Debt / EBITDA-2.13
Interest Coverage-1.63

Financial Efficiency

These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) is negative at -117.49, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 38.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.49 indicates how many times Nemaura Medical, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-117.49
Employee Count38.00
Inventory Turnover0.49

Stock Price Statistics

As of the close on November 16, 2026, Nemaura Medical, Inc.'s stock has declined approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

52-Week Price Change-50.00%

Income Statement

USD

Over the twelve months ended December 31, 2023, Nemaura Medical, Inc. generated - - in revenue and converted that into -10.65M in net income, yielding earnings per share of -0.38. EBITDA reached -9.23M, while operating income came in at -8.96M.

Gross Profit-1.48M
Operating Income-8.96M
Pretax Income-10.65M
Net Income-10.65M
EBITDA-9.23M
EBIT-9.71M
Earnings Per Share (EPS)-0.38

Balance Sheet

USD

As of December 31, 2023, Nemaura Medical, Inc. holds 137,416.00 in cash and equivalents against 19.64M in total debt, resulting in a net debt position of 19.51M. Total book value stands at -17.83M, with working capital of -18.62M providing operational flexibility.

Cash & Cash Equivalents137,416.00
Total Debt19.64M
Net Debt19.51M
Equity (Book Value)-17.83M
Book Value Per Share-0.62
Working Capital-18.62M

Cash Flow

USD

Nemaura Medical, Inc. produced -9.57M in operating cash flow over the twelve months ended December 31, 2023. After subtracting -177,219.00 in capital expenditures, free cash flow totaled -9.74M - equivalent to -0.34 per share.

Operating Cash Flow-9.57M
Capital Expenditures-177,219.00
Free Cash Flow-9.74M
FCF Per Share-0.34

Stock Splits

Nemaura Medical, Inc.'s most recent stock split took place on December 5, 2019 with a 10:1 split ratio.

Last Split Date12/5/2019
Split Ratio10:1